Inhibitory Activity of Drynariae rhizoma Extracts on Cathepsin Having Bone Resorption Activity

References

• Kalu D. N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 1991; 15: 175–192, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Ettinger B., Genant H. K., Cann C. E. Postmenopausal bone loss is presented by treatment with low‐dosage estrogen with calcium. Ann. Intern. Med. 1987; 106: 40–45, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Turk B., Turk D., Turk V. Lysosomal cysteine proteases: more than scavengers. Biochim. Biophys. Acta 2000; 1477: 98–111, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Storer A. C., Menard R. Catalytic mechanism in papain family of cysteine peptidases. Methods Enzymol. 1994; 244: 486–500, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Littlewood‐Evans A. J., Bilbe G., Bowler W. B., Farley D., Wlodarski B., Kokubo T., Inaoka T., Sloane J., Evans D. B., Gallagher J. A. The osteoclast‐associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 1997; 57: 5386–5390
   PubMed Web of Science ®Google Scholar
• Drake F. H., Dodds R. A., James I. E., Connor J. R., DeBouck C., Richardson S., Lee‐Rykaczewski E., Coleman L., Rieman D., Barthlow R., Hastings G., Gowen M. Cathepsin K, but not B, L or S is abundantly expressed in human osteoclasts. J. Biol. Chem. 1996; 271: 12511–12516, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rieman D. J., Mcclung H. A., Dodds R. A., Hwang S. M., Lark M. W., Holmes S., James I. E., Drake F. H., Gowen M. Biosynthesis and processing of cathepsin K in cultured human osteoblasts. Bone 2001; 28: 282–289, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Votta B. J., Levy M. A., Badger A., Dodds R. A., James I. E., Thompson S., Bossard M. J., Carr T., Connor J. R., Tomaszek T. A., Szewczuk L., Drake J. H., Veber D., Gowen M. Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vivo and in vitro. J. Bone Miner. Res. 1997; 12: 1396–1406, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Riese R. J., Mitchell R. N., Villadangos J. A., Shi G. P., Palmer J. T., Karp E. R., De Sanctis G. T., Ploegh H. L., Chapman H. A. Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 1998; 101: 2351–2363, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Everts V., Delaisse J. M., Korper W., Niehof A., Vacs G., Beertsen W. Degradation of collagen in the bone‐resorbing compartment underlying the osteoclast involves both cysteine‐proteinases and matrix metalloproteinases. J. Cell. Physiol. 1992; 150: 221–231, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Li Y. P., Alexander M., Wucherpfennig A. L., Yelick P., Chen W., Stashenko P. Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J. Bone Miner. Res. 1995; 10: 1197–2202, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Everts V., Delaisse J. M., Korper W., Beertsen W. Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J. Bone Miner. Res. 1998; 13: 1420–1430, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Falgueyret J. P., Oballa R. M., Okamoto O., Wesolowski G., Aubin Y., Rydzewski R. M., Rasit P., Riendeau D., Rodan S. B., Percival M. D. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsin K and L. J. Med. Chem. 2001; 44: 94–104, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kalu D. N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 1991; 15: 175–192, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Morris H. A., Need A. G., Horowitz M., O'Leughlin P. D., Nordin B. E.C. Calcium adsorption in normal and osteoporotic postmenopausal women. Calcif. Tissue Int. 1991; 48: 240–243
   PubMed Web of Science ®Google Scholar
• Agnusdei D., Comporeaale A., Zacchei F., Gennari C., Baroni M., Costi D., Biondi M., Passeri M., Ciacca A., Sbrenna C., Falsettini E., Ventura A. Effects of ipriflavone on bone mass and bone remodeling in patients with established postmenopausal osteoporosis. Curr. Ther. Res. 1992; 51: 82–91
   Web of Science ®Google Scholar
• Koyama T. Osteoporosis with Kampo treatment (in Japanese). Sanfujinka Chiryo 1991; 63: 203–207
   Google Scholar
• Xiu R. J. Microcirculation and traditional Chinese medicine. JAMA 1988; 269: 1755–1757, [CROSSREF]
   Web of Science ®Google Scholar
• Phillipson J. D., Anderson L. A. Ethnopharmacology and western medicine. J. Ethnopharmacol. 1989; 25: 61–72, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shi X. C. Chinese–English Terminology of Traditional Chinese Medicine. Hunan Science Publishing Co., China 1983; 71–98
   Google Scholar
• Terasawa K. Kampo: Japanese–Oriental Medicine. K. K. Standard McIntyre, TokyoJapan 1993
   Google Scholar
• Geng J., Huang W., Ren T., Ma X. F. Medicinal Herbs. New World Press, Beijing 1997; 226–227
   Google Scholar
• Hong S. N. A study of Drynariae rhizoma (DR) on bone‐metabolism. Ph.D. Thesis. Dongguk University Graduate School, KyungjuKorea 2001
   Google Scholar
• McCarthy T. L., Centrella M., Raisz L. G., Canalis E. Phosphoglandin E2 stimulates insulin‐like growth factor I synthesis in osteoblast‐enriched cultures from fetal rat bone. Endocrinology 1991; 128: 2895–2900, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McCarthy T. L., Centrella M., Canalis E. Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J. Bone Miner. Res. 1988; 3: 401–408, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kozikowski A. P., Fauq A. H. Synthesis of novel four‐membered ring amino acids as modulators of the n‐methyl‐d‐aspartate(NMDA) receptor complex. Synlett. 1991; 23: 783–784, [CROSSREF]
   Google Scholar
• Izquierdo‐Martin M., Stein R. L. Transition‐state structural features for the association of metalloproteases with phosphorus‐containing inhibitors. J. Am. Chem. Soc. 1992; 114: 1527–1528
   Web of Science ®Google Scholar
• Duggleby R. G., Attwood P. V., Wallace J. C., Keech D. B. Avidin is a slow‐binding inhibitor of pyruvate carboxylase. Biochemistry 1982; 21: 3364–3370, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hanzlik R. P., Zygmunt J., Moon J. B. Reversible covalent binding of peptide nitriles to papain. Biochim. Biophys. Acta 1990; 1035: 62–70, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• MacLeod A. M., Baker R., Freedman S. B., Patel S., Merchant K. J., Roe M., Saunders H. Synthesis and muscarinic activities of 1,2,4‐thiadiazoles. J. Med. Chem. 1990; 33: 2052–2059, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar